Our Kaplan-Meier survival analysis showed an interesting trend in patients with lower-grade glioma (LGG): lower CLEC18B expression was substantially linked with improved survival outcomes, whereas greater CLEC18B expression was significantly associated with considerably shorter 5-year OS and DSS ( Fig. 2 E).
← all excerpts
SP1-Mediated upregulation of CLEC18B promotes the proliferation and metastasis of glioma through regulation of the Wnt/β-Catenin/EMT Pathway.
1
—
—